NCT06633016: Study of ABX-002 for the Adjunctive Treatment of Major Depressive Disorder (AMPLIFY)
- State
- Under way
- Phase
- Phase 2
- People
- 230 planned
- Started
- 20 Sep 2024
- Primary completion
- Jun 2026
- Arms
- ABX-002 + SSRI/SNRI
- Results
- None posted
- 20 Sep 2024: Trial started
- 9 Oct 2024: Trial registered